Fidelity Investments’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.26K Sell
2,221
-1,012
-31% -$6.99K ﹤0.01% 4811
2025
Q4
$26.4K Buy
3,233
+422
+15% +$3.12K ﹤0.01% 4357
2025
Q3
$20.7K Sell
2,811
-328
-10% -$2.48K ﹤0.01% 4345
2025
Q2
$25.5K Buy
3,139
+722
+30% +$4.87K ﹤0.01% 4196
2025
Q1
$17K Buy
2,417
+388
+19% +$2.41K ﹤0.01% 4293
2024
Q4
$15.1K Buy
2,029
+504
+33% +$3.22K ﹤0.01% 4302
2024
Q3
$7.52K Buy
1,525
+105
+7% +$549 ﹤0.01% 4519
2024
Q2
$7.29K Sell
1,420
-70
-5% -$415 ﹤0.01% 4435
2024
Q1
$7.91K Sell
1,490
-3,615
-71% -$25.9K ﹤0.01% 4354
2023
Q4
$31.6K Buy
5,105
+3,209
+169% +$22.3K ﹤0.01% 3729
2023
Q3
$14.3K Sell
1,896
-297
-14% -$2.71K ﹤0.01% 3971
2023
Q2
$21.2K Buy
2,193
+166
+8% +$1.01K ﹤0.01% 3829
2023
Q1
$7.65K Buy
2,027
+1,921
+1,812% +$10.7K ﹤0.01% 4234
2022
Q4
$687 Sell
106
-333
-76% -$2.74K ﹤0.01% 4708
2022
Q3
$4K Sell
439
-856
-66% -$8.7K ﹤0.01% 4400
2022
Q2
$13K Buy
1,295
+36
+3% +$356 ﹤0.01% 4022
2022
Q1
$15K Buy
+1,259
New +$14K ﹤0.01% 4109
2013
Q4
Sell
-632,536
Closed -$7.72M 2659
2013
Q3
$7.72M Sell
632,536
-1,128,854
-64% -$15.8M ﹤0.01% 2034
2013
Q2
$23.3M Buy
+1,761,390
New +$24.4M ﹤0.01% 1595

Other funds holding LFCR